Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. RESEARCH, LICENSE AND COMMERCIALIZATION AGREEMENT between GLAXO GROUP LIMITED and VERTEX PHARMACEUTICALS...Research, License and Commercialization Agreement • March 16th, 2006 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 16th, 2006 Company Industry JurisdictionThis RESEARCH, LICENSE AND COMMERCIALIZATION AGREEMENT (this "Agreement") is effective as of December 12, 2005, (the "Effective Date") and is entered into by and between Glaxo Group Limited, a corporation organized under the laws of England, with offices at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN, United Kingdom ("GSK"), and Vertex Pharmaceuticals Incorporated, a Massachusetts corporation with corporate offices at 130 Waverly Street, Cambridge, MA 02139-4242, United States of America ("Vertex").
RESEARCH, LICENSE AND COMMERCIALIZATION AGREEMENTResearch, License and Commercialization Agreement • June 23rd, 2005 • Chemgenex Pharmaceuticals LTD • American depositary receipts • Victoria
Contract Type FiledJune 23rd, 2005 Company Industry Jurisdiction